AIG
CKPT

American International Group’s Checkpoint Therapeutics CKPT Stock Holding History

American International Group’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,017
Closed -$95 – 3144
2021
Q1 		$95 Buy
3,017
+9
+0.3% +$302 ﹤0.01% 2749
2020
Q4 		$80 Buy
3,008
+312
+12% +$7.89K ﹤0.01% 2759
2020
Q3 		$72K Buy
2,696
+198
+8% +$4.75K ﹤0.01% 2701
2020
Q2 		$49K Buy
2,498
+413
+20% +$7.53K ﹤0.01% 2882
2020
Q1 		$31K Buy
2,085
+553
+36% +$9.79K ﹤0.01% 2833
2019
Q4 		$26K Sell
1,532
-13
-0.8% -$218 ﹤0.01% 2987
2019
Q3 		$38K Buy
1,545
+79
+5% +$2.17K ﹤0.01% 2950
2019
Q2 		$45K Buy
+1,466
New +$57.5K ﹤0.01% 2967

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

American International Group's CKPT Position: Q2 2021 in Review

American International Group sold out of Checkpoint Therapeutics (CKPT) in Q2 2021, closing a stake of 3,017 shares — an estimated $95 sold.

American International Group first reported a position in CKPT in Q2 2019 and held it in 8 quarters. The position peaked at $72K in Q3 2020. 69 funds tracked by Wall St. Rank hold CKPT as of Q2 2021.

  • American International Group reported no remaining Checkpoint Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 3,017 Checkpoint Therapeutics shares in Q2 2021, an estimated $95.
  • American International Group first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 8 quarters.
  • American International Group's Checkpoint Therapeutics position peaked at $72K in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.